MAPK8, mitogen-activated protein kinase 8, 5599

N. diseases: 520; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0702166
Disease: Acne
Acne
0.010 Biomarker disease BEFREE GC-increased TLR2 expression was negatively regulated by JNK MAPK signalling when stimulated with Propionibacterium acnes. 28377308 2017
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.010 Biomarker disease BEFREE We conclude that overexpressed miR-330 suppresses atherosclerotic plaques formation while promotes VE cell proliferation by targeting MAPK8 through the WNT signaling pathway in ACS rats. 29236323 2018
CUI: C2118460
Disease: Acute colitis
Acute colitis
0.010 Biomarker disease BEFREE Using genetic mouse models, we characterized the role of JNK1 and JNK2 during homeostasis and acute colitis. 28098247 2017
CUI: C0948089
Disease: Acute Coronary Syndrome
Acute Coronary Syndrome
0.010 Biomarker disease BEFREE This study is designed to investigate the effects of microRNA (miR)-330 on atherosclerotic plaques formation and vascular endothelial (VE) cell proliferation by targeting MAPK8 through the WNT signaling pathway in rats with acute coronary syndrome (ACS). 29236323 2018
CUI: C0023440
Disease: Acute Erythroblastic Leukemia
Acute Erythroblastic Leukemia
0.010 AlteredExpression disease BEFREE JNK-mediated turnover and stabilization of the transcription factor p45/NF-E2 during differentiation of murine erythroleukemia cells. 19966288 2010
CUI: C0281773
Disease: Acute glaucoma
Acute glaucoma
0.010 Biomarker disease BEFREE Kaempferol attenuated retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via inhibiting NF-κB and JNK pathways in acute glaucoma. 30560913 2019
CUI: C0267797
Disease: Acute hepatitis
Acute hepatitis
0.010 Biomarker disease BEFREE Hepatoprotective effect of quercetin via TRAF6/JNK pathway in acute hepatitis. 29174851 2017
CUI: C0023449
Disease: Acute lymphocytic leukemia
Acute lymphocytic leukemia
0.010 AlteredExpression disease BEFREE These results suggested that anisomycin induced apoptosis of CEM-C1 cells via activation of p38 and JNK, and might be an attractive new agent for treatment of GC-resistant ALL. 23067223 2013
CUI: C0023465
Disease: Acute monocytic leukemia
Acute monocytic leukemia
0.030 Biomarker disease BEFREE Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2. 28518151 2017
CUI: C0023465
Disease: Acute monocytic leukemia
Acute monocytic leukemia
0.030 Biomarker disease BEFREE JNK1 as a signaling node in VDR-BRAF induction of cell death in AML. 28765039 2018
CUI: C0023465
Disease: Acute monocytic leukemia
Acute monocytic leukemia
0.030 Biomarker disease BEFREE Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML. 24842373 2014
CUI: C0155626
Disease: Acute myocardial infarction
Acute myocardial infarction
0.030 AlteredExpression disease BEFREE The increased KIM-1 and NGAL expression levels after MI in the OLETF kidney were associated with upregulated expression of TLR1, TLR2, TLR4, MyD88, IL-6, TNF-α, chemokine (C-C motif) ligand 2, and transforming growth factor-β<sub>1</sub> and also with activation of p38 MAPK, JNK, and NF-κB. 28822965 2017
CUI: C0155626
Disease: Acute myocardial infarction
Acute myocardial infarction
0.030 AlteredExpression disease BEFREE Using acute myocardial infarction rat models, we found that a combination therapy of CaSR inhibition and embryonic stem cell (ESC) transplantation after acute myocardial infarction (AMI) leads to a dramatic reduction in the infarct size; a significant increase in the maximum rising and falling rate (+dp/dtmax and -dp/dtmax, respectively) of left ventricular pressure; a significant decrease in left ventricular end-diastolic pressure; a significant decrease in the mRNA expression level of CaSR, Bax, Bcl-2, cleaved caspase-3, cleaved caspase-9, p-ERK, p-JNK and p-P38 protein together with apoptosis indexes in the C and E groups; and a significant decrease in cTnT levels as well as LDH and CK activity. 28281186 2017
CUI: C0155626
Disease: Acute myocardial infarction
Acute myocardial infarction
0.030 Biomarker disease BEFREE Fourth, CSWT inhibited activation of the JNK pathway, which indicated inhibition of the cell inflammatory pathways and promotion of cardiomyocyte survival after AMI. 30248666 2018
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.030 Biomarker disease BEFREE Differential JNK, p38 and ERK response to renal injury in a rat model of acute pancreatitis in pregnancy. 29349553 2018
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.030 AlteredExpression disease BEFREE MIP-1α induces inflammatory responses by upregulating chemokine receptor 1/chemokine receptor 5 and activating c-Jun N-terminal kinase and mitogen-activated protein kinase signaling pathways in acute pancreatitis. 30552706 2019
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.030 AlteredExpression disease BEFREE Inositol-requiring 1α (IRE1α)-mediated Jun N-terminal kinase (JNK)/nuclear factor-kappa B (NF-κB) pathway were activated early in AR42J cells and rat AP models. 29912856 2018
CUI: C0023487
Disease: Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia
0.010 Biomarker disease BEFREE Timosaponin AIII mediates caspase activation and induces apoptosis through JNK1/2 pathway in human promyelocytic leukemia cells. 25542232 2015
CUI: C0338106
Disease: Adenocarcinoma of colon
Adenocarcinoma of colon
0.010 Biomarker disease BEFREE PPA1 regulates tumor malignant potential and clinical outcome of colon adenocarcinoma through JNK pathways. 28938583 2017
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.050 AlteredExpression disease BEFREE In summary, our results showed that hsa-miR-623 was downregulated in lung adenocarcinoma and suppressed the invasion and metastasis targeting Ku80 through ERK/JNK inactivation mediated downregulation of MMP-2/9. 27685632 2016
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.050 Biomarker disease BEFREE In addition, RCC2 was able to activate JNK, while inhibition of JNK suppressed the effect of RCC2 on LUAD cell migration, invasion, EMT, and the expression of MMP-2 and MMP-9.<b>Conclusions:</b> RCC2 plays a pivotal role in LUAD metastasis by inducing EMT via activation of MAPK-JNK signaling.<i></i>. 28606921 2017
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.050 Biomarker disease BEFREE Furthermore, we demonstrated that human cMyc potently suppresses JNK-dependent cell invasion and migration in both Drosophila and lung adenocarcinoma cell lines. 28068320 2017
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.050 Biomarker disease BEFREE Cordycepin induces apoptosis by caveolin-1-mediated JNK regulation of Foxo3a in human lung adenocarcinoma. 28099944 2017
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.050 Biomarker disease BEFREE In this study, we further revealed that hypoxia induced 37-kDa laminin receptor precursor expression and activation of extracellular signal-regulated protein kinase, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase in lung adenocarcinoma cancer cells. 28618937 2017
CUI: C0281361
Disease: Adenocarcinoma of pancreas
Adenocarcinoma of pancreas
0.010 Biomarker disease BEFREE Here we studied the role of Wnt5a, p-JNK and p-paxillin protein expressions and functions in the further development of pancreatic adenocarcinoma. 24395444 2014